This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Charles River Laboratories Announces Organizational Changes To Enhance Global Capabilities

Charles River Laboratories International, Inc. (NYSE: CRL) today announced organizational changes which are designed to continue to improve the Company’s operating efficiency across its global portfolio and enhance its ability to meet the needs of its clients. These changes represent the next step in Charles River’s continuing effort to position the Company as the partner of choice for early-stage drug development and to drive future growth.

James C. Foster, Chairman, President and Chief Executive Officer, said, “In a market environment which is rapidly changing, we have continued to refine and enhance our competitive position through a combination of portfolio expansion, organizational changes, efficiency initiatives, improved data infrastructure and increasing scientific expertise. The changes we are announcing today are the logical evolution of these ongoing efforts, which we believe will ensure our clients a consistent and superior experience across our global organization. Furthermore, our intensified emphasis on efficiency will enable us to meet our clients’ expectations while maintaining and enhancing our reputation for service, responsiveness and scientific excellence.”

Enhanced Efficiency Initiatives

The organizational changes are designed to further enhance the Company’s worldwide productivity initiatives and promote the global management of its Research Models and Services (RMS) and Preclinical Services (PCS) businesses. The respective organizational changes are as follows:

Jörg Geller, D.V.M., Ph.D., previously Corporate Executive Vice President and President, European & Asian Operations, will now directly oversee a global initiative to enhance efficiency and drive increased productivity across all of Charles River’s businesses worldwide. In his new role, Dr. Geller will assume the title of Corporate Executive Vice President, Global Productivity and Efficiency. Dr. Geller will be responsible for intensifying the Company’s focus on driving productivity, while retaining its reputation for service, responsiveness and scientific excellence. This has become increasingly important to continue to meet clients’ expectations and maintain Charles River’s strong competitive position. Dr. Geller will lead a cross-sectional team of Charles River’s functional and business-unit leaders that will be tasked with the critical initiative to drive increased productivity and efficiency at an accelerated pace.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs